Clinical Trial Information

Lilly believes companies must act to earn the trust of the public they serve. To support this, Lilly supports responsible sharing of clinical study data and will continue to be an engaged partner in ongoing industry-wide discussions toward this goal.

Since 2002, Lilly has registered all Lilly-sponsored Phase II, Phase III and Phase IV clinical studies conducted anywhere in the world that were initiated on or after October 15, 2002, on Additionally, Lilly began registering all Phase I clinical studies commencing on or after October 1, 2010.

Lilly also provides updates to the European database ( regarding many aspects of clinical research and development, including the location of where clinical studies are being conducted.

Finally, Lilly also seeks to publish study results – both positive and negative – through other channels, such as peer-reviewed journals and scientific conferences.